Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

2.

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.

Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2004 May 15;55(10):1031-40.

PMID:
15121488
3.

Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.

Swanson J, Baler RD, Volkow ND.

Neuropsychopharmacology. 2011 Jan;36(1):207-26. doi: 10.1038/npp.2010.160. Epub 2010 Sep 29. Review.

4.

What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).

Advokat C.

Neurosci Biobehav Rev. 2010 Jul;34(8):1256-66. doi: 10.1016/j.neubiorev.2010.03.006. Epub 2010 Apr 8. Review.

PMID:
20381522
5.
6.

Similar effects of amphetamine and methylphenidate on the performance of complex operant tasks in rats.

Mayorga AJ, Popke EJ, Fogle CM, Paule MG.

Behav Brain Res. 2000 Apr;109(1):59-68.

PMID:
10699658
7.

Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.

Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH.

J Child Psychol Psychiatry. 2015 Jan;56(1):40-8. doi: 10.1111/jcpp.12272. Epub 2014 Jun 19.

8.

The use of stimulant medication to improve neurocognitive and learning outcomes in children diagnosed with brain tumours: a systematic review.

Smithson EF, Phillips R, Harvey DW, Morrall MC.

Eur J Cancer. 2013 Sep;49(14):3029-40. doi: 10.1016/j.ejca.2013.05.023. Epub 2013 Jul 4. Review.

PMID:
23831334
9.

Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.

Linssen AM, Sambeth A, Vuurman EF, Riedel WJ.

Int J Neuropsychopharmacol. 2014 Jun;17(6):961-77. doi: 10.1017/S1461145713001594. Epub 2014 Jan 15. Review.

PMID:
24423151
10.

Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.

Goez HR, Scott O, Nevo N, Bennett-Back O, Zelnik N.

J Child Neurol. 2012 Dec;27(12):1547-52. doi: 10.1177/0883073812439101. Epub 2012 Mar 23.

PMID:
22447850
11.

Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.

Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.

Eur J Pharmacol. 2008 Jan 14;578(2-3):148-58. Epub 2007 Oct 5.

12.

Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.

Marraccini ME, Weyandt LL, Rossi JS, Gudmundsdottir BG.

Exp Clin Psychopharmacol. 2016 Aug;24(4):269-84. doi: 10.1037/pha0000079. Review.

13.

Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.

Solanto MV.

Psychol Bull. 1984 May;95(3):387-409. Review. No abstract available.

PMID:
6152684
14.

The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs.

Albertson TE, Chenoweth JA, Colby DK, Sutter ME.

FP Essent. 2016 Feb;441:25-9. Review.

PMID:
26881770
15.

Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorder.

Tsai CS, Huang YS, Wu CL, Hwang FM, Young KB, Tsai MH, Chu SM.

BMC Psychiatry. 2013 Dec 4;13:330. doi: 10.1186/1471-244X-13-330.

17.

Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.

Advokat C, Scheithauer M.

Front Neurosci. 2013 May 29;7:82. doi: 10.3389/fnins.2013.00082. eCollection 2013.

18.

Effects of methylphenidate on attention and nonverbal learning in children with attention-deficit hyperactivity disorder.

O'Toole K, Abramowitz A, Morris R, Dulcan M.

J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):531-8.

PMID:
9100428
19.

Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.

Hammerness P, Fried R, Petty C, Meller B, Biederman J.

Child Neuropsychol. 2014;20(3):319-27. doi: 10.1080/09297049.2013.790359. Epub 2013 May 2.

PMID:
23639146
20.

Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.

Negrao BL, Bipath P, van der Westhuizen D, Viljoen M.

Neuropsychobiology. 2011;63(2):82-91. doi: 10.1159/000317548. Epub 2010 Dec 18.

PMID:
21178382

Supplemental Content

Support Center